首页 | 本学科首页   官方微博 | 高级检索  
检索        


Atherogenic properties of LDL particles after switching from Truvada or Kivexa plus lopinavir/r to lamivudine plus lopinavir/r: OLE-MET substudy
Authors:Maria Saumoy  Juan M Tiraboschi  Jordi Ordoñez-Llanos  Esteban Ribera  Pere Domingo  Josep Mallolas
Institution:1. HIV and STD Unit, Infectious Disease Service, Hospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Spain;2. Biochemistry Department, Biomedical Research Institute IIB Sant Pau, Barcelona, Spain;3. Infectious Disease Service, Hospital Universitari Vall d’Hebron, Universitat Autónoma de Barcelona, Barcelona, Spain;4. Department of Infectious Diseases, Hospitals Universitaris Arnau de Vilanova &5. Santa Maria, Institut de Recerca Biomèdica (IRBLLEIDA), Universitat de Lleida, Lleida, Spain;6. Infectious Disease Service, Hospital Clínic, Barcelona, Spain
Abstract:
Keywords:LDL particles  Lipoprotein-associated phospholipase A2  Lopinavir/ritonavir  Tenofovir  Abacavir  Lipid profile  Switch strategy
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号